SYF
83
4
NUE
51
3
HST
63
5
FRT
41
5
HRB
56
2
AEP
48
5
MAS
59
3
EXPE
77
5
KR
44
4
KHC
20
2
CNP
44
5
AMAT
46
6
LB
45
15
UPS
28
3
BXP
49
2
M
30
2
WYNN
15
-11
GT
60
13
EXR
57
7
CME
56
3
SYF
83
4
NUE
51
3
HST
63
5
FRT
41
5
HRB
56
2
AEP
48
5
MAS
59
3
EXPE
77
5
KR
44
4
KHC
20
2
CNP
44
5
AMAT
46
6
LB
45
15
UPS
28
3
BXP
49
2
M
30
2
WYNN
15
-11
GT
60
13
EXR
57
7
CME
56
3
Financhill
Back

Protagonist Therapeutics Vs. Entrada Therapeutics Industry Stock Comparison

Sell
44

PTGX
Protagonist Therapeutics

Last Price:
47.60
Seasonality Move:
18.58%
Buy
64

TRDA
Entrada Therapeutics

Last Price:
18.66
Seasonality Move:
-34.31%
Sell
44
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $45.90. The Score for PTGX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Entrada Therapeutics (TRDA) is a Buy

Is Entrada Therapeutics a Buy, Sell or Hold?

  • The current Entrada Therapeutics [TRDA] share price is $18.62. The Score for TRDA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • TRDA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $45.90
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.

TRDA Stock Price Chart

What is Entrada Therapeutics's stock price today?

  • The Entrada Therapeutics share price today is $18.62
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing buying pressure, which is a positive indicator for future bullish movement.

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.55 Buy
Relative Strength Index (14 RSI): 48.74 Sell
Chaikin Money Flow: 154951 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.55 - 47.39) Sell
Bollinger Bands (100): (35.98 - 45.9) Buy

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.46 Buy
Relative Strength Index (14 RSI): 68.97 Buy
Chaikin Money Flow: 153692 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.42 - 17.68) Buy
Bollinger Bands (100): (14.77 - 17.19) Buy

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.09 Sell
20-day SMA: 46.37 Sell
50-day SMA: 45.14 Buy
200-day SMA: 34.63 Buy
8-day EMA: 46.69 Sell
20-day EMA: 46.38 Sell
50-day EMA: 44.64 Buy
200-day EMA: 35.99 Buy

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.5 Buy
20-day SMA: 17.19 Buy
50-day SMA: 16.25 Buy
200-day SMA: 14.96 Buy
8-day EMA: 17.65 Buy
20-day EMA: 17.18 Buy
50-day EMA: 16.55 Buy
200-day EMA: 15.47 Buy

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.98 per share, and a decrease next year of $3.62 per share.

Entrada Therapeutics Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $3.79 per share.

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Entrada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):